Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 20;9:1323–1339. doi: 10.2147/JHC.S392056

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Huang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

High ARFIP2 expression was significantly associated with early recurrence/metastasis in HCC. (A) qPCR analysis of ARFIP2 expression in three HCC patient groups with different recurrence/metastasis times. (B) WB analysis of ARFIP2 expression in three HCC patient groups with different recurrence/metastasis times. (C) Representative image of ARFIP2 immunohistochemical staining in HCC tumour tissues and peritumor tissues. *P < 0.05, **P < 0.01; NR/M, patients with no r recurrence/metastasis within 24 months; R/M_{12–24 months}, patients with recurrence/metastasis within 12–24 months; R /M_{≤12 months}, patients with recurrence/metastasis within 12 months.